Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis

Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10

Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513

A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease

Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Powrie, F., Correa-Oliveira, R., Mauze, S., & Coffman, R. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.589 · Cited by 613

Role for protease activity in visceral pain in irritable bowel syndrome

Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 1×

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B. M., Cox, E., Remon, J. P., & Remaut, E. (2003) · Nature Biotechnology · doi:10.1038/nbt840 · Cited by 545

Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence.

Wiedow, O., Schröder, J. M., Gregory, H., Young, J. A., & Christophers, E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77182-2 · Cited by 433

Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.

Cénac, N., Coelho, A., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W., Wallace, J., Hollenberg, M., Bunnett, N., Garcia-Villar, R., et al. (2002) · American Journal of Pathology · doi:10.1016/s0002-9440(10)64466-5 · Cited by 386

Role of the microbiota in inflammatory bowel diseases

Nagalingam, N. A., & Lynch, S. V. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21866 · Cited by 315 · cited 1×

A Novel Mucosal Vaccine Based on Live Lactococci Expressing E7 Antigen and IL-12 Induces Systemic and Mucosal Immune Responses and Protects Mice against Human Papillomavirus Type 16-Induced Tumors

Bermúdez‐Humarán, L. G., Cortes‐Perez, N. G., Lefèvre, F., Guimarães, V., Rabot, S., Alcocer-González, J. M., Gratadoux, J., Rodrı́guez-Padilla, C., Taméz-Guerra, R. S., Corthier, G., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7297 · Cited by 191

CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT

Vergnolle, N. (2005) · Gut · doi:10.1136/gut.2004.048876 · Cited by 166

Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products

Brittain, N. Y., & Finbloom, J. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115663 · Cited by 34

Strategies for the Identification and Assessment of Bacterial Strains with Specific Probiotic Traits

Torres-Maravilla, E., Reyes-Pavón, D., Benítez‐Cabello, A., Gónzalez-Vázquez, R., Ramirez-Chamorro, L., Langella, P., & Bermúdez‐Humarán, L. G. (2022) · Microorganisms · doi:10.3390/microorganisms10071389 · Cited by 33

Protease-Activated Receptors as Therapeutic Targets in Visceral Pain

Cénac, N. (2013) · Current Neuropharmacology · doi:10.2174/1570159x113119990039 · Cited by 32

Living Therapeutics: The Next Frontier of Precision Medicine

Kelly, V. W., Liang, B. K., & Sirk, S. J. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00444 · Cited by 30

Protective effects of n‐6 fatty acids‐enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A 4 and its receptor

Gobbetti, T., Ducheix, S., Faouder, P. L., Pérez, T., Riols, F., Boué, J., Bertrand‐Michel, J., Dubourdeau, M., Guillou, H., Perretti, M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12957 · Cited by 31

Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice

Santiago, A., Hann, A., Constante, M., Rahmani, S., Libertucci, J., Jackson, K. J., Rueda, G. H., Rossi, L., Ramachandran, R., Ruf, W., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2205425 · Cited by 31

Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons

Bejaoui, M., Sokol, H., & Marteau, P. R. (2015) · Digestive Diseases · doi:10.1159/000437104 · Cited by 30

A new lactobacilliin vivoexpression system for the production and delivery of heterologous proteins at mucosal surfaces

Allain, T., Mansour, N. M., Bahr, M. M. A., Martín, R., Florent, I., Langella, P., & Bermúdez‐Humarán, L. G. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw117 · Cited by 30

Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease

Anderson, B. M., Poole, D. P., Aurelio, L., Ng, G. Z., Fleischmann, M. J., Kasperkiewicz, P., Morissette, C., Drąg, M., van Driel, I. R., Schmidt, B. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49840-4 · Cited by 30

Microbiome Therapeutics: A Path Toward Sustainable Healthcare

Kumar, T., & Chauhan, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00010-3 · Cited by 29

Pathophysiological roles of proteases in gastrointestinal disease

Edgington‐Mitchell, L. E. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00393.2015 · Cited by 29

IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis

Wang, X., Kaiser, H., Kvist‐Hansen, A., McCauley, B. D., Skov, L., Hansen, P. R., & Becker, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010555 · Cited by 30

High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures

Wang, J., ORTIZ, C. W., Fontenot, L., Xie, Y., Ho, W. W., Mattai, S. A., Shih, D. Q., & Koon, H. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231796 · Cited by 28

Transglutaminase as a therapeutic target for celiac disease

Sulic, A., Kurppa, K., Rauhavirta, T., Kaukinen, K., & Lindfors, K. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.985207 · Cited by 28

Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model

Aubry, C., Michon, C., Chain, F., Chvatchenko, Y., Goffin, L., Zimmerli, S. C., Guin, S. L., Langella, P., Bermúdez‐Humarán, L. G., & Chatel, J. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0367-5 · Cited by 28

Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease

Zhang, W., Teng, G., Wu, T., Tian, Y., & Wang, H. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001252 · Cited by 28

Advancement of Engineered Bacteria for Orally Delivered Therapeutics

Guo, P., Wang, S., Yue, H., Zhang, X., Ma, G., Li, X., & Wei, W. (2023) · Small · doi:10.1002/smll.202302702 · Cited by 27

Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2

Rondeau, L. E., da Luz, B. B., Santiago, A., Bermúdez-Brito, M., Hann, A., Palma, G. D., Jury, J. A., Wang, X., Verdu, E. F., Galipeau, H. J., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387857 · Cited by 26

GSK3β, a Master Kinase in the Regulation of Adult Stem Cell Behavior

Racaud‐Sultan, C., & Vergnolle, N. (2021) · Cells · doi:10.3390/cells10020225 · Cited by 29

Toward Practical Applications of Engineered Living Materials with Advanced Fabrication Techniques

Lu, C., Huang, Y., Cui, J., Wu, J., Jiang, C., Gu, X., Cao, Y., & Yin, S. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00259 · Cited by 27

Live bacterial biotherapeutics in the clinic

Bermúdez‐Humarán, L. G., & Langella, P. (2018) · Nature Biotechnology · doi:10.1038/nbt.4248 · Cited by 26

The double-edged sword of gut bacteria in celiac disease and implications for therapeutic potential

Galipeau, H. J., & Verdu, E. F. (2022) · Mucosal Immunology · doi:10.1038/s41385-021-00479-3 · Cited by 30

Elafin and its precursor trappin‐2: What is their therapeutic potential for intestinal diseases?

Deraison, C., Bonnart, C., Langella, P., Roget, K., & Vergnolle, N. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15985 · Cited by 26

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

Caruso, J. A., Karakaş, C., Zhang, J., Yi, M., Albarracin, C. T., Şahin, A. A., Bondy, M. L., Liu, J., Hunt, K. K., & Keyomarsi, K. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0497-4 · Cited by 26

Engineered Live Biotherapeutics: Progress and Challenges

Tan, Y., Shen, J., Si, T., Ho, C. L., Li, Y., & Dai, L. (2020) · Biotechnology Journal · doi:10.1002/biot.202000155 · Cited by 26

Gut Serpinome: Emerging Evidence in IBD

Mkaouar, H., Mariaule, V., Rhimi, S., Hernandez, J. L., Kriaa, A., Jablaoui, A., Akermi, N., Maguin, E., Lesner, A., Korkmaz, B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116088 · Cited by 23

Drug resistance in inflammatory bowel diseases

Moreau, J., & Mas, E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.11.003 · Cited by 25

W-GA nanodots restore intestinal barrier functions by regulating flora disturbance and relieving excessive oxidative stress to alleviate colitis

Li, Q., Zhang, C., Zhu, M., Shan, J., Qian, H., Ma, Y., & Wang, X. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.05.030 · Cited by 24

Oral delivery of pancreatitis‐associated protein by Lactococcus lactis displays protective effects in dinitro‐benzenesulfonic‐acid‐induced colitis model and is able to modulate the composition of the microbiota

Breyner, N. M., Boas, P. C. B. V., Fernandes, G. D. R., Carvalho, R. D. D. O., Rochat, T., Michel, M., Chain, F., Sokol, H., de Azevedo, M. S. P., Myioshi, A., et al. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14748 · Cited by 24

The frontier of health: Exploring therapeutic potentials of the microbiome

Abavisani, M., Foroushan, S. K., Kesharwani, P., & Sahebkar, A. (2025) · PharmaNutrition · doi:10.1016/j.phanu.2025.100435 · Cited by 23

Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease

Dong, Y., Xu, T., Xiao, G., Hu, Z., & Chen, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.909591 · Cited by 23

A DNA Nanopatch‐Bacteriophage System Targeting Streptococcus Gallolyticus for Inflammatory Bowel Disease Treatment and Colorectal Cancer Prevention

Zhao, Y., Zhu, M., Ling, Y., Zhao, Y., Lu, X., Chu, B., He, Y., & Wang, H. (2025) · Advanced Materials · doi:10.1002/adma.202417334 · Cited by 25

Sialylation regulates neutrophil transepithelial migration, CD11b/CD18 activation, and intestinal mucosal inflammatory function

Azcutia, V., Kelm, M., Fink, D., Cummings, R. D., Nusrat, A., Parkos, C. A., & Brazil, J. C. (2023) · JCI Insight · doi:10.1172/jci.insight.167151 · Cited by 22

Gut flora in multiple sclerosis: implications for pathogenesis and treatment

Zhang, W., Wang, Y., Zhu, M., Liu, K., & Zhang, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.387974 · Cited by 24

Development of bacteria as diagnostics and therapeutics by genetic engineering

Lim, D., & Song, M. (2019) · The Journal of Microbiology · doi:10.1007/s12275-019-9105-8 · Cited by 22

Human neutrophil IL1β directs intestinal epithelial cell extrusion during Salmonella infection

Lawrence, A.-L. E., Berger, R. P., Hill, D. R., Huang, S., Yadagiri, V. K., Bons, B., Fields, C., Sule, G. J., Knight, J. S., Wobus, C. E., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010855 · Cited by 21

Alternating magnetic field-responsive engineered probiotics for anxiety therapy via gut-brain axis modulation

Wang, X., Zhang, Y., Chang, Y., Zhu, Y., Xiang, G., Chen, K., Feng, C., Hang, Z., Li, X., & Zhang, D. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03551-3 · Cited by 23

Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications

Woloszynek, S., Pastor, S. J., Mell, J. C., Nandi, N., Sokhansanj, B. A., & ROSEN, G. L. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.01.003 · Cited by 20

Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2

Xie, Y., Fontenot, L., Estrada, A. C., Nelson, B., Wang, J., Shih, D. Q., Ho, W. W., Mattai, S. A., Rieder, F., Jensen, D. D., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.06.011 · Cited by 20

Secretion of an immunoreactive single-chain variable fragment antibody against mouse interleukin 6 by Lactococcus lactis

Shigemori, S., Ihara, M., Sato, T., Yamamoto, Y., Nigar, S., Ogita, T., & Shimosato, T. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7907-8 · Cited by 20

Toward Microbiome Engineering: Expanding the Repertoire of Genetically Tractable Members of the Human Gut Microbiome

Marsh, J. W., Kirk, C., & Ley, R. E. (2023) · Annual Review of Microbiology · doi:10.1146/annurev-micro-032421-112304 · Cited by 19

Efficient treatment of a preclinical inflammatory bowel disease model with engineered bacteria

Ferenczi, S., Solymosi, N., Horváth, I. T., Szeőcs, N., Grózer, Z., Kuti, D., Juhász, B., Winkler, Z., Pankotai, T., Sükösd, F., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.11.010 · Cited by 18

Bacteria-Based Microdevices for the Oral Delivery of Macromolecules

Cao, Z., Lin, S., & Liu, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101610 · Cited by 18

Protease‐activated receptor 2 contributes to Toxoplasma gondii‐mediated gut inflammation

Bonnart, C., Feuillet, G., Vasseur, V., Cénac, N., Vergnolle, N., & Blanchard, N. (2017) · Parasite Immunology · doi:10.1111/pim.12489 · Cited by 19

Clinical significance of PI3 and HLA-DOB as potential prognostic predicators for ovarian cancer

Li, Y., Li, H., Yang, B., Wei, J., Zhen, C., & Feng, L. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.11.30 · Cited by 18

Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats

Hanning, N., bruyn, M. D., Ceuleers, H., Boogaerts, T., Berg, M., Smet, A., Schepper, H. U. D., Joossens, J., van Nuijs, A. L. N., Man, J. G. D., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060811 · Cited by 18

The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?

Brandi, G., Turroni, S., McAllister, F. M., & Frega, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189914 · Cited by 19

Synthetic gutomics: Deciphering the microbial code for futuristic diagnosis and personalized medicine

Satapathy, P., Khan, K., Devi, A. T., Patil, A. G., Govindaraju, A. M., Gopal, S., Prasad, M. N. N., More, V. S., Kakarla, R. R., Raghu, A. V., et al. (2019) · Methods in microbiology · doi:10.1016/bs.mim.2019.02.001 · Cited by 17

In vitro assembly of plasmid DNA for direct cloning in Lactiplantibacillus plantarum WCSF1

Blanch‐Asensio, M., Dey, S., & Sankaran, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281625 · Cited by 16

The proteolytic activity in inflammatory bowel disease: insight from gut microbiota

Hou, J., Ding, L., Yang, T., Yang, Y.-F., Jin, Y., Zhang, X., Ma, A.-H., & Qin, Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106560 · Cited by 20

PEARL: Protein Eluting Alginate with Recombinant Lactobacilli

Tadimarri, V. S., Blanch‐Asensio, M., Deshpande, K., Baumann, J., Baumann, C., Müller, R., Trujillo, S., & Sankaran, S. (2025) · Small · doi:10.1002/smll.202408316 · Cited by 16

Design of Asynchronous Genetic Circuits

Nguyen, T., Jones, T. S., Fontanarrosa, P., Mante, J. V., Zundel, Z., Densmore, D. M., & Myers, C. J. (2019) · Proceedings of the IEEE · doi:10.1109/jproc.2019.2916057 · Cited by 16

Genome alterations associated with improved transformation efficiency in Lactobacillus reuteri

Ortiz-Velez, L., Ortiz-Villalobos, J., Schulman, A., Oh, J., van Pijkeren, J., & Britton, R. A. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-0986-8 · Cited by 17

The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome

Hou, J., Wang, X., Li, Y., Su, S., Wang, Y., & Wang, B. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104995 · Cited by 18

Biological markers of disease activity in inflammatory bowel diseases

Szymańska, E., Szymańska, S., Dądalski, M., & Kierkuś, J. (2023) · Gastroenterology Review · doi:10.5114/pg.2023.129412 · Cited by 15

From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel disease

Huang, Y., Peng, S., Zeng, R., Yao, H., Feng, G., & Fang, J. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127928 · Cited by 19

3-Oxo-β-sultam as a Sulfonylating Chemotype for Inhibition of Serine Hydrolases and Activity-Based Protein Profiling

Carvalho, L. A. R., Almeida, V. T., Brito, J. A., Lum, K. M., Oliveira, T. F., Guedes, R. C., Gonçalves, L., Lucas, S. D., Cravatt, B. F., Archer, M., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00090 · Cited by 15

Challenges and Pitfalls in the Engineering of Human Interleukin 22 (hIL-22) Secreting Lactobacillus reuteri

Ortiz-Velez, L., Goodwin, A., Schaefer, L., & Britton, R. A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00543 · Cited by 15

Applying the design-build-test paradigm in microbiome engineering

Pham, H. L., Ho, C. L., Wong, A., Lee, Y. S., & Chang, M. W. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.021 · Cited by 16

Engineering Diagnostic and Therapeutic Gut Bacteria

Landry, B. P., & Tabor, J. J. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch14 · Cited by 12

Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review

Zahedifard, Z., Mahmoodi, S., & Ghasemian, A. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2738 · Cited by 12

PAR-1 Antagonism to Promote Gut Mucosa Healing in Crohn’s Disease Patients: A New Avenue for CVT120165

Motta, J., Deraison, C., Grand, S. L., Grand, B. L., & Vergnolle, N. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab244 · Cited by 11

Effects of 1‐week sacral nerve stimulation on the rectal intestinal epithelial barrier and neuromuscular transmission in a porcine model

Provost, M., Brégeon, J., Aubert, P., Duchalais, É., d'Aldebert, E., Vergnolle, N., Neunlist, M., & Meurette, G. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12465 · Cited by 11

Clinical Significance of Serum Elafin in Children with Inflammatory Bowel Disease

Krawiec, P., & Pac‐Kożuchowska, E. (2022) · Biomedicines · doi:10.3390/biomedicines10123267 · Cited by 10

Genetic Tools for the Enhancement of Probiotic Properties

Ortiz-Velez, L., & Britton, R. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0018-2016 · Cited by 10

The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model

Spaendonk, H. V., Ceuleers, H., Smet, A., Berg, M., Joossens, J., der Veken, P. V., Francque, S., Lambeir, A., Man, J. G. D., Meester, I. D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.682065 · Cited by 9

A culture-based method for determining the production of secreted protease inhibitors

Quintero, D. A., & Bermudes, D. G. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.02.019 · Cited by 10

High Expression and Clinical Significance of Elafin in Colorectal Cancer

Liu, Y., Tian, Y., Wu, T., Dai, Y., Wang, W., & Teng, G. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/4946824 · Cited by 9

Microbiome engineering: unlocking therapeutic potential in inflammatory bowel disease

Chen, K., Huang, L.-B., Yang, M., Yue, N.-N., Luo, D., Zhang, Y., Tian, C., Song, Y., Wei, D., Shi, R., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1610029 · Cited by 11

Aqueous two-phase system cold-set gelation using natural and recombinant probiotic lactic acid bacteria as a gelling agent

Léonard, L., Husson, F., Langella, P., Chatel, J., & Saurel, R. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.057 · Cited by 9

The gut–kidney axis in high-altitude hypoxia: pathophysiological mechanisms and the central role of hypoxia inducible factor

Wu, P., Li, X., Long, W., Ma, Y., Xue, B., Xie, W., & Ma, X. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2557514 · Cited by 13

Proteases in intestinal health and disease

Deraison, C., & Vergnolle, N. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01129-w · Cited by 9

The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult

Ceuleers, H., Hanning, N., bruyn, M. D., Man, J. G. D., Schepper, H. U. D., Li, Q., Liu, L., Abrams, S., Smet, A., Joossens, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.765744 · Cited by 8

Engineering microbial living therapeutics

Pedrolli, D. B., Ribeiro, N. V., Squizato, P. N., Cozetto, D. A., de Jesus, V. N., Freire, P. J. C., Lins, M. R. C. R., & Corrêa, G. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00008-3 · Cited by 6

Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer’s Disease

Wang, Y., & Dykes, G. A. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210806165751 · Cited by 8

Mucosal delivery of allergen peptides expressed by Lactococcus lactis inhibit allergic responses in a BALB/c mouse model

Ai, C., Zhang, Q., Ding, J., Wang, G., Liu, X., Tian, F., Zhao, J., Zhang, H., & Chen, W. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7187-8 · Cited by 8

Use of Traditional and Genetically Modified Probiotics in Human Health: What Does the Future Hold?

Bermúdez‐Humarán, L. G., & Langella, P. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0016-2016 · Cited by 11

Oligomerized backbone pilin helps piliated Lactococcus lactis to withstand shear flow

Castelain, M., Duviau, M.-P., Oxaran, V., Schmitz, P., Cocaign‐Bousquet, M., Loubière, P., Piard, J.-C., & Mercier‐Bonin, M. (2016) · Biofouling · doi:10.1080/08927014.2016.1213817 · Cited by 8

Engineering Lactic Acid Bacteria and Bifidobacteria for Mucosal Delivery of Health Molecules

Allain, T., Aubry, C., Natividad, J. M., Chatel, J., Langella, P., & Bermúdez‐Humarán, L. G. (2015) · Wiley eBooks · doi:10.1002/9781118868386.ch11 · Cited by 8

Versatile whey acidic protein four-disulfide core domain proteins: biology and role in diseases

Wen, Y., Jiang, N., Wang, Z., & Xiao, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1459129 · Cited by 7

Bowel preparation before colonoscopy: Consequences, mechanisms, and treatment of intestinal dysbiosis

Zheng, Z.-L., Zheng, Q.-F., Wang, L., & Liu, Y. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i2.100589 · Cited by 9

Pharmacology of Intestinal Inflammation and Repair

Deraison, C., & Vergnolle, N. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-084536 · Cited by 7

Harnessing the Potential of Lactobacillus Species for Therapeutic Delivery at the lumenal-mucosal Interface

Spangler, J. R., Caruana, J. C., Medintz, I. L., & Walper, S. A. (2021) · Future Science OA · doi:10.2144/fsoa-2020-0153 · Cited by 7

Elafin—a potential IBD therapy

Greenhill, C. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.223 · Cited by 7

Comprehensive analysis of heterogeneity and cell-cell interactions in Crohn’s disease reveals novel location-specific insights

Feng, J., He, L.-N., Yao, R., Qiao, Y., Yang, T., Cui, Z., Meng, X., Tong, J., Jia, K., Zuo, Z., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.042 · Cited by 6

Microbiota–Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases

Chin, S. W., Low, Z. Y., Tan, W. Q., & Azman, A. S. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70043 · Cited by 6

Dysbiosis and Therapeutic Modulation of the Gut Microbiota in Multiple Sclerosis: A Narrative Review

Memariani, M., & Memariani, H. (2025) · Health Science Reports · doi:10.1002/hsr2.71564 · Cited by 5

Mechanisms of chronic abdominal pain in inflammatory bowel disease and implications for treatment

Defaye, M., Nasser, Y., & Altier, C. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01139-8 · Cited by 7

Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation

Plavec, T. V., Klemenčič, K., Kuchař, M., Malý, P., & Berlec, A. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106568 · Cited by 5

Use of Rgg quorum-sensing machinery to create an innovative recombinant protein expression system in Streptococcus thermophilus

Gardan, R., Honvo‐Houeto, E., Mézange, C., Maillot, N. J., Balvay, A., Rabot, S., Bermúdez‐Humarán, L. G., Langella, P., Monnet, V., & Juillard, V. (2024) · Microbiology · doi:10.1099/mic.0.001487 · Cited by 5

Natural Compounds in the Modulation of the Intestinal Microbiota: Implications in Human Physiology and Pathology

Spisni, E., Turroni, S., Shahaj, S., Spigarelli, R., Ayala, D., & Valerii, M. C. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94043 · Cited by 7

Key Considerations in the Selection of Ingredients and Processing Technologies for Functional Foods and Nutraceutical Products

Singh, A., & Orsat, V. (2014) · Wiley eBooks · doi:10.1002/9781118504956.ch3 · Cited by 6

Increased Bacterial Proteolytic Activity Detected Before Diagnosis of Ulcerative Colitis

Galipeau, H. J., Caminero, A., & Verdu, E. F. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab144 · Cited by 5

Engineering commensal microbes for host health

Brown, E. A., Brevi, A., Zong, D. M., & Zarrinpar, A. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.025 · Cited by 4

Proteases

Deraison, C., Bonnart, C., & Vergnolle, N. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch28 · Cited by 4

Recombinant Lactococcus lactis Expressing Human LL-37 Prevents Deaths from Viral Infections in Piglets and Chicken

Zhang, H., Dong, M., Xu, H., Li, H., Zheng, A., Sun, G., & Jin, W. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10155-6 · Cited by 4

Treatment of gluten-related disorders

Yoosuf, S., & Makharia, G. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821846-4.00006-1 · Cited by 4

Gut Homeostasis; Microbial Cross Talks in Health and Disease Management

Khatri, G. S., Kurian, C., Anand, A., & Paari, K. A. (2021) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.9.3.28 · Cited by 3

Microbiome Diagnostics and Interventions in Health and Disease

Dasgupta, N., Srivastava, A., Rao, A., Murugkar, V., Shroff, R., & Das, G. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_10 · Cited by 3

Antimicrobial Peptides: An Emerging Approach to Treating Colitis

Tran, D. H.-N., & Koon, H. W. (2016) · Cited by 3

Elafin—a potential IBD therapy

Greenhill, C. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.223 · Cited by 7

A gardian of gut epithelial barrier from inflammation: the elastase inhibitor ELAFIN

Deraison, C., Jaeger, M.-C., Guiraud, L., Rolland, C., Bellot, A., Rolland, C., Sebbag, M., Bermúdez‐Humarán, L. G., Langella, P., & Vergnolle, N. (2020) · The FASEB Journal · doi:10.1096/fasebj.2020.34.s1.05293

IBD's bacteria cafeteria

Lou, K.-J. (2012) · Science-Business eXchange · doi:10.1038/scibx.2012.1154

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota

Teng, G., Li, H., Liu, Y., Wu, T., Dai, Y., Wang, H., & Wang, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.819336 · Cited by 56

Elafin-secreting lactic acid bacteria for treating inflammatory bowel disease (IBD)

(2012) · Science-Business eXchange · doi:10.1038/scibx.2012.1174 · Cited by 1